Alternative Name: ENG + EE Vaginal Ring

Description: EluRyng® is the first generic version of the NuvaRing®. It is a monthly vaginal ring, inserted for 3 weeks and removed for 1 week, with etonogestrel (ENG) and ethinyl estradiol (EE).

Product Details

User: Female

Hormonal: Yes

Delivery Method: Vaginal Ring

Duration Type: Short-acting

Duration: 1 month

  • Inserted for 3 weeks and removed for 1 week

Dose: 0.120 mg ENG + 0.015 mg EE per day

Active Pharmaceutical Ingredient (API):
  • etonogestrel
  • ethinyl estradiol

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Amneal

Project Phase: Limited Market Availability

Development Stage: SRA/WHO PQ Approved

Active Development: Yes

Status Details:
  • EluRyng® has received FDA approval.

Additional Information


Vertical Tabs